Prevention of irinotecan plus 5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer

被引:32
作者
Alimonti, A [1 ]
Satta, F
Pavese, I
Burattini, E
Zoffoli, V
Vecchione, A
机构
[1] Univ Rome La Sapienza 2, Rome, Italy
[2] San Pietro Hosp, Rome, Italy
关键词
D O I
10.1093/annonc/mdg193
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:805 / 806
页数:2
相关论文
共 5 条
  • [1] GUPTA E, 1994, CANCER RES, V54, P3723
  • [2] Kehrer DFS, 2001, CLIN CANCER RES, V7, P1136
  • [3] Rivory LP, 1997, CLIN CANCER RES, V3, P1261
  • [4] Sparreboom A, 1998, CLIN CANCER RES, V4, P2747
  • [5] Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats
    Takasuna, K
    Hagiwara, T
    Hirohashi, M
    Kato, M
    Nomura, M
    Nagai, E
    Yokoi, T
    Kamataki, T
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (04) : 280 - 286